Pictured: Kenneth Chang, MD, Vincent and Anna Kong Chair in Gastrointestinal Edoscopic Oncology, and executive director of the UCI Health Digestive Health Institute
The American Society of Gastrointestinal Endoscopy (ASGE) has named Dr. Kenneth Chang, board-certified UCI Health gastroenterologist and executive director of the UCI Health Digestive Health Institute, a Crystal Awards Master Endoscopist honoree.
The prestigious Crystal Awards is the annual recognition of gastroenterologists who have made a tremendous contribution to the field of gastrointestinal (GI) endoscopy.
“I am truly honored to be named a 2022 ASGE Master Endoscopist award recipient,” said Dr. Chang. “My entire academic career has been devoted to the field of GI endoscopy – embracing the invigorating cycle of discover-teach-heal. To be recognized as a Master Endoscopist affirms my passion and calling to this space. I share this award with all those who taught, mentored, and inspired me, as well as those who endured my discipleship.”
Dr. Chang has a longstanding history of advancing the standards of care for those suffering from digestive diseases. For more than three decades, his clinical research has focused on developing and expanding the field of interventional gastrointestinal endoscopy with a specific focus on digestive malignancies and precancerous lesions.
Being the first to term ‘interventional endoscopy’ and ‘interventional endoscopic ultrasound (EUS)’ in 1997, he has continuously brought novel disruptive technologies to the field, including EUS-guided fine needle aspiration (FNA) for cancer diagnosis and staging, radiofrequency ablation (RFA) in the treatment of Barrett’s esophagus, EUS-guided portal pressure gradient (EUS-PPG) measurement for patients with suspected liver cirrhosis, and endoscopic treatment for gastro-esophageal reflux disease (GERD).
Dr. Chang holds the Vincent and Anna Kong Chair in Gastrointestinal Endoscopic Oncology – one of the few chairs in gastrointestinal endoscopic oncology in the nation – and has published over 470 peer-review articles, review papers, book chapters and abstracts, and has edited four textbooks. These scientific publications include five major topics: EUS-guided tissue acquisition, new diagnostic approaches to pancreatic cystic neoplasia, endo-hepatology, GERD/Barrett’s esophagus, and third-space endoscopy (myotomy and cancer resection).
Over the past decade, Dr. Chang has focused on pre-cancerous conditions of the digestive system (Barrett’s esophagus and pancreatic cysts) with the goal to improve detection, risk stratification and clinical strategies that culminate in a personalized approach toward treatment and cure. He also views acid reflux and obesity as being precursors (pre-pre-cancer) to malignancy and has developed impactful, minimally invasive procedures to manage both.
In addition to his expertise in GI malignancies and Barrett’s, Dr. Chang is an expert in peroral endoscopic myotomy (POEM) in the treatment of achalasia, endoscopic submucosal resection (ESD) of early cancers and endoscopic sleeve gastroplasty (ESG) for obesity. He is also an authority on trans-oral incisionless fundoplication (TIF) in the treatment of GERD.